The emerging role of the CTLA-4 gene in autoimmune endocrinopathies

European Journal of Endocrinology

Volumn 150, Issue 5, 2004, Pages 619-626

  Vaidya, Bijay ^b   Pearce, Simon ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADDISON DISEASE; AUTOIMMUNE DISEASE; DISEASE PREDISPOSITION; ENDOCRINE DISEASE; ENVIRONMENTAL FACTOR; GENE FUNCTION; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENOTYPE ENVIRONMENT INTERACTION; GRAVES DISEASE; HEREDITY; HUMAN; HYPOTHYROIDISM; INHERITANCE; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

ADDISON DISEASE; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; AUTOIMMUNE DISEASES; CHROMOSOME MAPPING; DIABETES MELLITUS, TYPE 1; ENDOCRINE SYSTEM DISEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; THYROID DISEASES;

EID: 2942738825     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1500619     Document Type: Review

References (94)

1. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M et al. Positional cloning of the APECED gene. Nature Genetics 1997 17 393-398.
2. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nature Genetics 2001 27 18-20.
3. Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M, Suzan M, Mattei MG et al. A new member of the immunoglobulin superfamily - CTLA-4. Nature 1987 328 267-270.
4. Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994 1 405-413.
5. Okazaki T, Iwai Y & Honjo T. New regulatory co-receptors: inducible co-stimulator and PD-1. Current Opinion in Immunology 2002 14 779-782.
6. Watanabe N, Gavrieli M, Sedy JR, Yang J, Fallarino F, Loftin SK et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nature Immunology 2003 4 670-679.
7. Krummel MF & Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. Journal of Experimental Medicine 1995 182 459-465.
8. Leach DR, Krummel MF & Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science 1996 271 1734-1736.
9. McCoy K, Camberis M & Gros GL. Protective immunity to nematode infection is induced by CTLA-4 blockade. Journal of Experimental Medicine 1997 186 183-187.
10. Murphy ML, Cotterell SE, Gorak PM, Engwerda CR & Kaye PM. Blockade of CTLA-4 enhances host resistance to the intracellular pathogen. Leishmania donovani. Journal of Immunology 1998 161 4153-4160.
11. Kirman J, McCoy K, Hook S, Prout M, Delahunt B, Orme I, Frank A & Le Gros G. CTLA-4 blockade enhances the immune response induced by mycobacterial infection but does not lead to increased protection. Infection and Immunity 1999 67 3786-3792.
12. Perrin PJ, Maldonado JH, Davis TA, June CH & Racke MK. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. Journal of Immunology 1996 157 1333-1336.
13. Luhder F, Hoglund P, Allison JP, Benoist C & Mathis D. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. Journal of Experimental Medicine 1998 187 427-432.
14. Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W & Gibson MG. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA-4Ig. Science 1992 257 789-792.
15. Finck BK, Linsley PS & Wofsy D. Treatment of murine lupus with CTLA-4Ig. Science 1994 265 1225-1227.
16. Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. Journal of Experimental Medicine 1995 181 1145-1155.
17. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995 270 985-988.
18. Krummel MF & Allison JP. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. Journal of Experimental Medicine 1996 183 2533-2540.
19. Scheipers P & Reiser H. Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking. PNAS 1998 95 10083-10088.
20. Gribben JG, Freeman GJ, Boussiotis VA, Rennert P, Jellis CL, Greenfield E et al. CTLA4 mediates antigen-specific apoptosis of human T cells. PNAS 1995 92 811-815.
21. Thompson CB & Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity 1997 7 445-450.
22. Marengere LE, Waterhouse P, Duncan GS, Mittrucker HW, Feng GS & Mak TW. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 1996 272 1170-1173.
23. Lee KM, Chuang E, Griffin M, Khattri R, Hong DK, Zhang W et al. Molecular basis of T cell inactivation by CTLA-4. Science 1998 282 2263-2266.
24. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M & DeGroot LJ. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. Journal of Clinical Endocrinology and Metabolism 1995 80 41-45.
25. Nisticò L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Human Molecular Genetics 1996 5 1075-1080.
26. Kotsa K, Watson PF & Weetman AP. A CTLA-4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism. Clinical Endocrinology 1997 46 551-554.
27. Sale MM, Akamizu T, Howard TD, Yokota T, Nakao K, Mori T et al. Association of autoimmune thyroid disease with a microsatellite marker for the thyrotropin receptor gene and CTLA-4 in a Japanese population. Proceedings of the Association of American Physicians 1997 109 453-461.
28. Akamizu T, Sale MM, Rich SS, Hiratani H, Noh JY, Kanamoto N et al. Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients. Thyroid 2000 10 851-858.
29. Hadj Kacem H, Bellassoued M, Bougacha-Elleuch N, Abid M & Ayadi H. CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease. Clinical Immunology 2001 101 361-365.
30. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R et al. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1997 82 143-146.
31. Marron MP, Raffel LJ, Garchon HJ, Jacob CO, Serrano-Rios M, Martinez Larrad MT et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Human Molecular Genetics 1997 6 1275-1282.
32. Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, Ban Y et al. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 1997 7 843-846.
33. Awata T, Kurihara S, Iitaka M, Takei S, Inoue I, Ishii C et al. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 1998 47 128-129.
34. Djilali-Saiah I, Larger E, Harfouch-Hammoud E, Timsit J, Clerc J, Bertin E et al. No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM. Diabetes 1998 47 125-127.
35. Heward JM, Allahabadia A, Armitage M, Hattersley A, Dodson PM, Macleod K et al. The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. Journal of Clinical Endocrinology and Metabolism 1999 84 2398-2401.
36. Buzzetti R, Nisticò L, Signore A & Cascino I. CTLA-4 and HLA gene susceptibility to thyroid-associated orbitopathy. Lancet 1999 354 1824.
37. Chen QY, Nadell D, Zhang XY, Kukreja A, Huang YJ, Wise J et al. The human leukocyte antigen HLA DRB3*020/DOA1*0501 haplotype is associated with Graves' disease in African Americans. Journal of Clinical Endocrinology and Metabolism 2000 85 1545-1549.
38. Park YJ, Chung HK, Park DJ, Kim WB, Kim SW, Koh JJ et al. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 2000 10 453-459.
39. Chistyakov DA, Savost'anov KV, Turakulov RI, Petunina NA, Trukhina LV, Kudinova AV et al. Complex association analysis of graves disease using a set of polymorphic markers. Molecular Genetics and Metabolism 2000 70 214-218.
40. Villanueva R, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES et al. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology. Thyroid 2000 10 791-798.
41. Allahabadia A, Heward JM, Nithiyananthan R, Gibson SM, Reuser TT, Dodson PM et al. MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease. Lancet 2001 358 984-985.
42. Kinjo Y, Takasu N, Komiya I, Tomoyose T, Takara M, Kouki T, Shimajiri Y et al. Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene. Journal of Clinical Endocrinology and Metabolism 2002 87 2593-2596.
43. Yung E, Cheng PS, Fok TF & Wong GW. CTLA-4 gene A-G polymorphism and childhood Graves' disease. Clinical Endocrinology 2002 56 649-653.
44. Kouki T, Gardine CA, Yanagawa T & Degroot LJ. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease. Journal of Endocrinological Investigation 2002 25 208-213.
45. Vaidya B, Oakes EJ, Imrie H, Dickinson AJ, Perros P, Kendall-Taylor P et al. CTLA-4 gene and Graves' disease: association of Graves' disease with the CTLA-4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism. Clinical Endocrinology 2003 58 732-735.
46. Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, Osikowska M et al. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations. European Journal of Endocrinology 2003 148 13-18.
47. Mochizuki M, Amemiya S, Kobayashi K, Kobayashi K, Shimura Y, Ishihara T et al. Association of the CTLA-4 gene 49 A/G polymorphism with type 1 diabetes and autoimmune thyroid disease in Japanese children. Diabetes Care 2003 26 843-847.
48. Kalantari T, Mostafavi H, Pezeshki AM, Farjadian S, Doroudchi M, Yeganeh F et al. Exon-1 polymorphism of CTLA-4 gene in Iranian patients with Graves' disease. Autoimmunity 2003 36 313-316.
49. Braun J, Donner H, Siegmund T, Walfish PG, Usadel KH & Badenhoop K. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 1998 51 563-566.
50. Heward JM, Allahabadia A, Carr-Smith J, Daykin J, Cockram CS, Gordon C et al. No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies. Clinical Endocrinology 1998 49 331-334.
51. Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D et al. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Human Molecular Genetics 1999 8 1195-1199.
52. Vaidya B, Kendall-Taylor P & Pearce SHS. The genetics of autoimmune thyroid disease. Journal of Clinical Endocrinology and Metabolism 2002 87 5385-5397.
53. Vaidya B, Imrie H, Perros P, Dickinson J, McCarthy MI, Kendall-Taylor P et al. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy. Lancet 1999 354 743-744.
54. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML & DeGroot LJ. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. Journal of Immunology 2000 165 6606-6611.
55. Petrone A, Giorgi G, Mesturino CA, Capizzi M, Cascino I, Nistico L et al. Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid 2001 11 171-175.
56. Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. Journal of Clinical Endocrinology and Metabolism 1997 82 4130-4132.
57. Nithiyananthan R, Heward JM, Allahabadia A, Franklyn JA & Gough SC. Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid 2002 12 3-6.
58. Tomoyose T, Komiya I, Takara M, Yabiku K, Kinjo Y, Shimajiri Y et al. Cytotoxic T-lymphocyte antigen-4 gene polymorphisms and human T-cell lymphotrophic virus-1 infection: their associations with Hashimoto's thyroiditis in Japanese patients. Thyroid 2002 12 673-677.
59. Tomer Y, Greenberg DA, Barbesino G, Concepcion E & Davies TF. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. Journal of Clinical Endocrinology and Metabolism 2001 86 1687-1693.
60. Zaletel K, Krhin B, Gaberscek S, Pirnat E & Hojker S. The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease. Thyroid 2002 12 373-386.
61. Tomer Y, Barbesino G, Greenberg DA, Concepcion E & Davies TF. Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. Journal of Clinical Endocrinology and Metabolism 1999 84 4656-4664.
62. Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K et al. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Human Molecular Genetics 2001 10 1379-1386.
63. Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA et al. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. American Journal of Human Genetics 2003 73 736-747.
64. Jin Y, Teng W, Ben S, Xiong X, Zhang J, Xu S et al. Genome-wide scan of Graves' disease: evidence for linkage on chromosome 5q31 in Chinese Han pedigrees. Journal of Clinical Endocrinology and Metabolism 2003 88 1798-1803.
65. Esposito L, Hill NJ, Pritchard LE, Cucca F, Muxworthy C, Merriman ME et al. Genetic analysis of chromosome 2 in type 1 diabetes: analysis of putative loci IDDM7, IDDM12, and IDDM13 and candidate genes NRAMP1 and IA-2 and the interleukin-1 gene cluster. Diabetes 1998 47 1797-1799.
66. Marron MP, Zeidler A, Raffel LJ, Eckenrode SE, Yang JJ, Hopkins DI et al. Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA-4-D2S105 on chromosome 2q33. Diabetes 2000 49 492-499.
67. Lowe RM, Graham J, Sund G, Kockum I, Landin-Olsson M, Schaefer JB et al. The length of the CTLA-4 microsatellite (AT)N-repeat affects the risk for type 1 diabetes. Autoimmunity 2000 32 173-180.
68. Ihara K, Ahmed S, Nakao F, Kinukawa N, Kuromaru R, Matsuura N et al. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population. Immunogenetics 2001 53 447-454.
69. Ban Y, Taniyama M, Tozaki T, Yanagawa T, Yamada S, Maruyama T et al. No association of type 1 diabetes with a microsatellite marker for CTLA-4 in a Japanese population. Autoimmunity 2001 34 39-43.
70. Graham J, Hagopian WA, Kockum I, Li LS, Sanjeevi CB, Lowe RM et al. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002 51 1346-1355.
71. Van der Auwera BJ, Vandewalle CL, Schuit FC, Winnock F, De Leeuw IH, Van Imschoot S et al. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. Clinical and Experimental Immunology 1997 110 98-103.
72. Krokowski M, Bodalski J, Bratek A, Machejko P & Caillat-Zucman S. CTLA-4 gene polymorphism is associated with predisposition to IDDM in a population from central Poland. Diabetes and Metabolism 1998 24 241-243.
73. Hayashi H, Kusaka I, Nagasaka S, Kawakami A, Rokkaku K, Nakamura T et al. Association of CTLA-4 polymorphism with positive anti-GAD antibody in Japanese subjects with type 1 diabetes mellitus. Clinical Endocrinology 1999 51 793-799.
74. Yanagawa T, Maruyama T, Gomi K, Taniyama M, Kasuga A, Ozawa Y et al. Lack of association between CTLA-4 gene polymorphism and IDDM in Japanese subjects. Autoimmunity 1999 29 53-56.
75. Abe T, Takino H, Yamasaki H, Ozaki M, Sera Y, Kondo H et al. CTLA4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes. Diabetes Research and Clinical Practice 1999 46 169-175.
76. Lee YJ, Huang FY, Lo FS, Wang WC, Hsu CH, Kao HA et al. Association of CTLA4 gene A-G polymorphism with type 1 diabetes in Chinese children. Clinical Endocrinology 2000 52 153-157.
77. Kikuoka N, Sugihara S, Yanagawa T, Ikezaki A, Kim HS, Matsuoka H et al. Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies. Clinical Endocrinology 2001 55 597-603.
78. Takara M, Komiya I, Kinjo Y, Tomoyose T, Yamashiro S, Akamine H et al. Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease. Diabetes Care 2000 23 975-978.
79. Klitz W, Bugawan TL, Panelo A, Solfelix CM, Buzzetti R, Pozzilli P et al. Association of CTLA-4 variation with type I diabetes in Filipinos. Immunogenetics 2002 54 310-313.
80. Ongagna JC, Sapin R, Pinget M & Belcourt A. Markers for risk of type 1 diabetes in relatives of Alsacian patients with type 1 diabetes. International Journal of Experimental Diabetes Research 2002 3 1-9.
81. Fajardy I, Vambergue A, Stuckens C, Weill J, Danze PM & Fontaine P. CTLA-4 49 A/G dimorphism and type 1 diabetes susceptibility: a French case-control study and segregation analysis. Evidence of a maternal effect. European Journal of Immunogenetics 2002 29 251-257.
82. Cinek O, Drevinek P, Sumnik Z, Bendlova B, Kolouskova S, Snajderova M et al. The CTLA4 + 49 A/G dimorphism is not associated with type 1 diabetes in Czech children. European Journal of Immunogenetics 2002 29 219-222.
83. Ma Y, Tang X, Chang W, Gao L, Li M & Yan W. CTLA-4 gene A/G polymorphism associated with diabetes mellitus in Han Chinese. Chinese Medical Journal 2002 115 1248-1250.
84. Lee YJ, Lo FS, Shu SG, Wang CH, Huang CY, Liu HF et al. The promoter region of the CTLA4 gene is associated with type 1 diabetes mellitus. Journal of Pediatric Endocrinology and Metabolism 2001 14 383-388.
85. Kemp EH, Ajjan RA, Husebye ES, Peterson P, Uibo R, Imrie H et al. A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients. Clinical Endocrinology 1998 49 609-613.
86. Vaidya B, Imrie H, Geatch DR, Perros P, Ball SG, Baylis PH et al. Association analysis of the cytotoxic T lymphocyte antigen-4 and autoimmune regulator-1 genes in sporadic autoimmune Addison's disease. Journal of Clinical Endocrinology and Metabolism 2000 85 688-691.
87. Agarwal K, Jones DE, Daly AK, James OF, Vaidya B, Pearce S et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. Journal of Hepatology 2000 32 538-541.
88. Harbo HF, Celius EG, Vartdal F & Spurkland A. CTLA-4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens 1999 53 106-110.
89. Djilali-Saiah I, Schmitz J, Harfouch-Hammoud E, Mougenot JF, Bach JF & Caillat-Zucman S. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut 1998 43 187-189.
90. Seidl C, Donner H, Fischer B, Usadel KH, Seifried E, Kaltwasser JP et al. CTLA-4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens 1998 51 62-66.
91. Vaidya B, Pearce SH, Charlton S, Marshall N, Rowan AD. Griffiths ID et al. An association between the CTLA-4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. Rheumatology 2002 41 180-183.
92. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G et al. Association of the T-cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature 2003 423 506-511.
93. Oaks MK & Hallett KM. A soluble form of CTLA-4 in patients with autoimmune thyroid disease. Journal of Immunology 2000 164 5015-5018.
94. Daroszewski J, Frydecka I, Pawlak E, Bolanowski M & Kochanowska I. Soluble CTLA-4 concentration in Graves' disease patients. Abstract of The European Thyroid Association. 2003 P-074 www.hotthyroidology.com/eta2003/poster-session/